These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25442165)

  • 21. A fast, comprehensive screening method for doping agents in urine by gas chromatography-triple quadrupole mass spectrometry.
    Van Eenoo P; Van Gansbeke W; De Brabanter N; Deventer K; Delbeke FT
    J Chromatogr A; 2011 May; 1218(21):3306-16. PubMed ID: 20970803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance-enhancing drugs and supplements in women and girls.
    Matich AJ
    Curr Sports Med Rep; 2007 Dec; 6(6):387-91. PubMed ID: 18001612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic growth hormone releasers detected in seized drugs: new trends in the use of drugs for performance enhancement.
    Stensballe A; McVeigh J; Breindahl T; Kimergård A
    Addiction; 2015 Feb; 110(2):368-9. PubMed ID: 25602046
    [No Abstract]   [Full Text] [Related]  

  • 24. Nutritional supplements cross-contaminated and faked with doping substances.
    Geyer H; Parr MK; Koehler K; Mareck U; Schänzer W; Thevis M
    J Mass Spectrom; 2008 Jul; 43(7):892-902. PubMed ID: 18563865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sports Medicine: Ergogenic Aids.
    Ketterly J
    FP Essent; 2022 Jul; 518():23-28. PubMed ID: 35830325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Veterinary medicines and competition animals: the question of medication versus doping control.
    Toutain PL
    Handb Exp Pharmacol; 2010; (199):315-39. PubMed ID: 20204593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone abuse in sports: the antidoping perspective.
    Barroso O; Mazzoni I; Rabin O
    Asian J Androl; 2008 May; 10(3):391-402. PubMed ID: 18385901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Forensic-medical diagnostics of doping cases in sports].
    Khodasevich LS; Kuzin SG; Khodasevich AL
    Sud Med Ekspert; 2013; 56(6):47-51. PubMed ID: 25474922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pheromones: a new ergogenic aid in sport?
    Papaloucas M; Kyriazi K; Kouloulias V
    Int J Sports Physiol Perform; 2015 Oct; 10(7):939-40. PubMed ID: 25710097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance-enhancing substances.
    Breuner CC
    Adolesc Med State Art Rev; 2014 Apr; 25(1):113-25. PubMed ID: 25022190
    [No Abstract]   [Full Text] [Related]  

  • 31. Making Decisions About Supplement Use.
    Maughan RJ; Shirreffs SM; Vernec A
    Int J Sport Nutr Exerc Metab; 2018 Mar; 28(2):212-219. PubMed ID: 29565185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anabolic and lipolytic actions of beta
    Hostrup M; Jacobson GA; Jessen S; Lemminger AK
    Drug Test Anal; 2020 May; 12(5):597-609. PubMed ID: 31960603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding performance-enhancing drug use.
    Wang D
    Conn Med; 2012 Sep; 76(8):487-91. PubMed ID: 23061215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ecdysteroids as non-conventional anabolic agent: performance enhancement by ecdysterone supplementation in humans.
    Isenmann E; Ambrosio G; Joseph JF; Mazzarino M; de la Torre X; Zimmer P; Kazlauskas R; Goebel C; Botrè F; Diel P; Parr MK
    Arch Toxicol; 2019 Jul; 93(7):1807-1816. PubMed ID: 31123801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contamination of dietary supplements and positive drug tests in sport.
    Maughan RJ
    J Sports Sci; 2005 Sep; 23(9):883-9. PubMed ID: 16195040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Doping--also a problem in general practice?].
    Dickhuth HH; Berg A; Baumstark M; Rokitzki L; Huonker M; Keul J
    Fortschr Med; 1989 Sep; 107(28):585-8. PubMed ID: 2613151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research of stimulants and anabolic steroids in dietary supplements.
    Baume N; Mahler N; Kamber M; Mangin P; Saugy M
    Scand J Med Sci Sports; 2006 Feb; 16(1):41-8. PubMed ID: 16430680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doping with growth hormone/IGF-1, anabolic steroids or erythropoietin: is there a cancer risk?
    Tentori L; Graziani G
    Pharmacol Res; 2007 May; 55(5):359-69. PubMed ID: 17349798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sports doping: emerging designer and therapeutic β2-agonists.
    Fragkaki AG; Georgakopoulos C; Sterk S; Nielen MW
    Clin Chim Acta; 2013 Oct; 425():242-58. PubMed ID: 23954776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.